A report on Rosie Latimer’s presentation “Clinical Features of Mycoplasma Genitalium Associated Pelvic Inflammatory Disease and Response to Moxifloxacin: A Case Series” as well as Ruthy McIver’s presentation "Men who have sex with men with Mycoplasma genitalium are more likely to have macrolide resistant strains than men with only female partners: a prospective study”
“Clinical Features of Mycoplasma genitalium associated Pelvic Inflammatory Disease and response to Moxifloxacin: a Case Series”
As a sexual health doctor in the era of Mycoplasma genitalium’s (MG) fast increasing resistance to available antibiotics and a paucity of antibiotic choice, I frequently face conundrums around the treatment of patients with MG. Previous meta-analyses have shown MG has a role in Pelvis Inflammatory Disease (PID) but there is little evidence on the characteristics of MG-associated PID. The findings of this study specifically comparing chlamydial and MGPID therefore interested me.
The aims of this first study were 2-fold: (1) to describe the clinical characteristics of MG PID and to determine how they differ from those associated with Chlamydial PID (CT-PID). (2) To determine the proportion of women cured of MG-PID following 14 days of Moxifloxacin, either by NAAT test or clinical cure.